As of Mar 27
| +0.07 / +1.02%|
The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 7.50, with a high estimate of 7.50 and a low estimate of 7.50. The median estimate represents a +7.91% increase from the last price of 6.95.
The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.